Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma 2019-12-11 08:41
Kazia wins ANZLF Trans-Tasman Innovation & Growth Award and reports new data from clinical trial in childhood brain cancer 2019-09-13 20:00
St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway 2019-09-12 21:10
Australian cancer specialists may hold key to next advancement in ovarian cancer treatment 2017-08-31 06:00
GDC-0084 Progress Update: On Track for Phase II Commencement in 2017 2017-08-22 12:06
Progress Update on Cantrixil(TM) (TRXE-002-1) Development 2017-08-07 11:03
Novogen Provides Update On Development Of Cantrixil 2016-05-02 10:43
Studies Confirm TRXE-009 Crosses the Blood-brain Barrier 2015-06-05 07:30
Australian Studies Confirm TRXE-009 Kills Resistant Paediatric Brain Cancer Cells 2015-05-08 06:54
Australian Studies Confirm Anisina as Potential Important New Weapon Against Melanoma 2015-04-09 11:06
Potential of Anisina to Become Major New Chemotherapy Confirmed by Coda Study 2015-03-19 04:00
Sky News, Helen Dalley interviews Dr Graham Kelly 2015-03-10 12:28
1